Skaraborg Hospital-Vaestra Goetalandsregionen
- Address
- lock Available on a paid plan
Infectious Diseases and Antimicrobial Research
At Skaraborg Hospital-Vaestra Goetalandsregionen, clinical trials in Bacterial Infections and Mycoses and Virus Diseases focus on improving treatment for difficult infections and reducing complications from serious pathogens. Studies are exploring better antibiotic strategies for resistant urinary tract infections and bacteremia, as well as new ways to lessen the impact of Tick-Borne Encephalitis.
- New treatment options for resistant urinary tract infections and bloodstream infections
- Therapies aimed at improving outcomes in Staphylococcus aureus bacteremia
- Research on reducing brain injury during Tick-Borne Encephalitis infection
This area combines infection control, symptom reduction, and evaluation of therapies that may improve recovery in challenging infectious diseases.
Cardiovascular and Metabolic Disease Studies
The site has an active portfolio in Cardiovascular Diseases, Nutritional and Metabolic Diseases, and related kidney-heart conditions, with trials addressing stroke prevention, heart failure, and vascular risk reduction. Research includes patients with Atrial fibrillation, Heart failure with preserved ejection fraction, and high-risk atherosclerotic disease, often aiming to improve long-term protection against major cardiovascular events.
- Stroke prevention strategies in atrial fibrillation with advanced kidney disease
- Testing therapies to lower risk in high cardiovascular risk patients
- Evaluating treatments for heart failure and Takotsubo syndrome
These studies are designed to refine prevention and treatment approaches for serious heart and circulation disorders.
Neurology, Stroke, and Eye Health Research
Clinical research in Nervous System Diseases and Eye Diseases at the hospital addresses urgent neurological conditions and vision-threatening disorders. Trials are studying recovery after acute ischemic stroke and Facial Nerve Palsy, while other work evaluates prevention of Retinopathy of Prematurity in vulnerable newborns.
- Improving functional recovery after acute ischemic stroke
- Testing treatments for Bells Palsy in children
- Preventing severe eye damage from Retinopathy of Prematurity
The research goal is to support earlier intervention and better outcomes in neurologic and ophthalmic care.
Cancer and Hematology Trials
The oncology portfolio covers Neoplasms and Hemic and Lymphatic Diseases, with studies spanning Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Acute Myeloid Leukaemia, and Pediatric Cancer. These trials are focused on testing new treatment combinations, improving recurrence control, and strengthening anti-cancer immune responses.
- Evaluating new treatment approaches for advanced and metastatic cancers
- Improving survival and recurrence prevention in solid tumors
- Studying treatment effectiveness in acute myeloid leukaemia and childhood cancer
This research reflects a broad effort to improve cancer outcomes across both adult and pediatric populations.
Autoimmune, Hormonal, and Maternal Health Research
Trials in Musculoskeletal Diseases, Hormonal diseases, and Female Urogenital Diseases and Pregnancy Complications address chronic inflammatory conditions, endocrine care, and obstetric management. The site is studying Rheumatoid arthritis, Type 1 diabetes, and labor induction, with the aim of improving symptom control, treatment adherence, and safety in routine care.
- Comparing treatment options for early rheumatoid arthritis
- Investigating immune-preserving therapy in newly diagnosed type 1 diabetes
- Assessing outpatient approaches for induction of labour
These studies support more personalized and practical care across autoimmune, hormonal, and maternity-related fields.
Psychiatry and Behavioral Health Studies
Research in Mental Disorders at the Infektionskliniken includes work on challenging psychiatric sexual disorders, combining psychological therapy with medical treatment to reduce harmful behavior. The trial program is aimed at improving risk management and supporting safer, more effective care for affected participants.
- Testing cognitive behavioral therapy approaches for sexual behavior disorders
- Evaluating whether added medical treatment can further reduce risk
- Studying behavioral interventions for prevention of harmful sexual offending
This area highlights the use of structured therapy to address complex mental health and behavioral concerns.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 12 therapeutic areas and 15 of 49 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 46 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
- 1Vaestra Goetalandsregionen5active
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Vaestra Goetalandsregionen6trials
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Skaraborg Hospital-Vaestra Goetalandsregionen
lock Showing 1 of 22 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy and Tolerability of Oral Versus Subcutaneous Methotrexate in Early Rheumatoid Arthritis: A Randomized Multicenter Study | — | Phase III | Not Recruiting | Apr 2022 | — |
IMP list
lock Showing 1 of 49 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin | 2 | Unknown | 2023-04-17 | 2023-10-26 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.